Simergent, LLC develops the Archimedes automated peritoneal dialysis system, a home dialysis device designed to be affordable, easy to use, and accessible for patients with end-stage kidney disease. The device is FDA cleared for both clinic and home use, allowing patients to undergo treatment without requiring a caregiver.
Subscribe to see Simergent, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Simergent, LLC is a medical devices company headquartered in United States. It has raised at least $10M across the 2 funding rounds on record. Its most recent funding round raised $8.8M in March 2024. Xcout tracks 4 named people at Simergent, LLC, including Steve J Lindo (Manager and Chief Executive Officer).
At least $10M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $8.8M | — | |
| Seed | $1.2M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Simergent, LLC's closest competitors — see the full list of competitors and alternatives →
AWAK Technologies (now operating as Vivance) develops medical technology solutions for comprehensive kidney care, including ultraportable and wearable dialysis devices, point-of-care dialysis fluid generation, and digital AI integration for remote patient monitoring. The company serves patients with chronic kidney disease and end-stage renal disease by providing portable and personalized treatment options.
AposHealth provides a personalized, FDA-cleared foot-worn medical device designed for the home treatment of chronic knee, hip, and back pain, accompanied by clinical support.
Patensee develops a contactless imaging and artificial intelligence system designed for hemodialysis clinics to monitor patient vascular access sites. The technology aims to standardize physical examinations and enable the early prediction of stenosis and other complications for dialysis patients.
SymPhysis Medical is a medical technology company that develops the rel eaze™ Drainage System, an intuitive device designed for at-home pleural effusion management. The product aims to provide patients suffering from chronic conditions like cancer with a less invasive and more independent method for symptom drainage.
CeQur is a medical device company headquartered in Horw, Switzerland, with operational headquarters in Greenville, South Carolina. It is dedicated to making insulin delivery easy through wearable devices like the CeQur Simplicity patch.
Accuryn Medical, also known as Potrero Medical, is an American medical technology company based in Hayward, California. The company transforms critical care monitoring with the Accuryn Monitoring System, providing real-time data to help clinicians manage fluid levels and address Acute Kidney Injury.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.